Global Small Animal (In-Vivo) Imaging Market, By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Application (Monitoring Drug treatment response, Bio distribution Studies, Cancer cell Detection, Biomarkers, Longitudinal Studies, Epigenetics) – Industry Trends and Forecast to 2029
Global Small Animal (In-Vivo) Imaging Market Analysis and Size
Small animal (in-vivo) imaging market is estimated to increase rapidly over the forecast period. Small animal imaging operations employ a variety of in-vivo techniques. These techniques are gaining traction and are being used to define mechanisms of action, target receptors, and conduct epigenetic research. The development and usage of multimodal instruments has grown rapidly in recent years, both in the preclinical and clinical stages of research. Dual-modality or hybrid PET/CT scanners are recommended; nevertheless, SPECT/CT scanners are already commonly utilized for regular analysis.
- Data Bridge Market Research analyses that the small animal (in-vivo) imaging market was valued at USD 910.4 million in 2021 and is expected to reach USD 1,697.61 million by 2029, registering a CAGR of 8.1% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Small Animal (In-Vivo) Imaging Market Definition
Small animal imaging (in-vivo) devices are a new type of diagnostic tool that may be used to diagnose a wide range of diseases in laboratory animals. Cancer cell research, monitoring drug response during drug development, examining the bio-distribution patterns of new chemical entities, biomarker research in animal models, longitudinal studies, and other disciplines all use a variety of small animal imaging (in-vivo) technologies. These devices have grown in popularity, and they are mostly employed in epigenetic research, receptor targeting, and determining the mechanism of action.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Application (Monitoring Drug treatment response, Bio distribution Studies, Cancer cell Detection, Biomarkers, Longitudinal Studies, Epigenetics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Bruker (U.S.), General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), Siemens Healthcare GmbH (Germany), FUJIFILM Corporation (Japan), PerkinElmer Inc. (U.S.), Miltenyi Biotec (Germany), CMR Naviscan (U.S.), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd. (Israel), Mediso Ltd. (V.A.), LI-COR, Inc. (USA), Takara Bio Inc. (Japan), MILabs B.V. (Netherlands), M.R. Solutions (U.K.), Trifoil Imaging (U.S.), New England Biolabs (U.S.), Biospace Lab (France), Guerbet (France), Agilent Technologies, Inc.(U.S.), Thermo Fisher Scientific Inc. (U.S.)
|
|
Market Opportunities
|
|
Small Animal (In-Vivo) Imaging Market Dynamics
Drivers
- Increasing use of multimodal imaging instruments
Over the projected period, rising use of multimodal imaging instruments expected to increase the market.
- Growing expenditure for healthcare sector
Moreover, the rising expenditure for the healthcare sector will enhance the small animal (in-vivo) imaging market growth.
Furthermore, increasing adoption of non-invasive technology for small animal imaging projected to propel the market forward. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the small animal (in-vivo) imaging market. Also, increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of small animal (in-vivo) imaging market. Small animal imaging systems and reagents have a wide range of uses in oncology, especially with the rise in cancer incidence around the world. The rising frequency of cardiovascular disorders is likely to boost the global small animal imaging market's growth in the cardiology application area.
Opportunities
- Increase in pharmaceutical industry and R&D expenditure
An increase in pharmaceutical industry and R&D expenditure will provide beneficial opportunities for the small animal (in-vivo) imaging market growth. The creation and usage of multimodal imaging devices has seen remarkable expansion in the ongoing evolution of imaging technology. Pharmaceutical businesses' increased R&D spending is a direct result of changing industry structure, particularly the rise of the biotechnology section.
Moreover, growing focus of manufacturers on the adoption of advanced technologies in field of healthcare and increase in the number of emerging markets will further provide beneficial opportunities for the small animal (in-vivo) imaging market growth during the forecast period.
Restraints/Challenges Global Small Animal (In-Vivo) Imaging Market
- Strict regulations
The presence of strict regulations will impede the market’s growth rate during the forecast period. One of the greatest impediments to the small animal imaging business is strict regulation. Distinct countries' regulatory agencies have different sets of rules for the application of medical devices, leaving product makers in an unclear situation.
On the other hand, low healthcare expenditure in developing countries and the lack of common standards will challenge the small animal (in-vivo) imaging market. Additionally, the lack of skilled professionals and low awareness will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.
This small animal (in-vivo) imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the small animal (in-vivo) imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Small Animal (In-Vivo) Imaging Market
The COVID-19 outbreak boosted the market for small animal (in-vivo) imaging. The majority of patients infected with COVID-19 have mild to moderate symptoms and recover at home, but some demanded medical intervention. COVID-19 appears to have a significant impact on the market.
In order to contain the COVID-19 spread, numerous governments enforced transit and travel restrictions, causing international trade and transportation to be hampered. As a result, the supply chain for small animal (in-vivo) imaging was interrupted, resulting in a temporary decrease in product demand. The market operators' capacity to offer small animal (in-vivo) imaging devices and apply previously sold products has been hampered by limited access to present and potential clients, resulting in a modest reduction in the growth rate in 2020. However, the supply chain disruption is projected to be mitigated in 2021, and the market is expected to develop at a faster rate during the projection period.
Global Small Animal (In-Vivo) Imaging Market Scope
The small animal (in-vivo) imaging market is segmented on the basis of modality, reagents, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Modality
- Optical Imaging Systems
- Nuclear Imaging Systems
- Micro-MRI
- Micro-Ultrasound
- Micro-CT
- Photoacoustic Imaging Systems
- Magnetic Particle Imaging Systems
On the basis of modality, the small animal (in-vivo) imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-mri, micro-ultrasound, micro-CT, photoacoustic imaging systems and magnetic particle imaging systems. Optical imaging systems have further been segmented into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems and optical + X-ray/optical + C.T. Nuclear imaging systems have further been segmented into micro-PET systems, micro-SPECT systems and trimodality (SPECT/PET/CT) systems.
Reagents
- Optical Imaging Reagents
- Nuclear Imaging Reagents
- MRI Contrast Agents
- Ultrasound Contrast Agents
- CT Contrast Agents
Based on reagents, the small animal (in-vivo) imaging market is segmented into optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents and C.T. contrast agents. Optical imaging reagents have further been segmented into bioluminescent imaging reagents and fluorescent imaging reagents. Nuclear imaging reagents have further been segmented into PET tracers and SPECT probes. MRI contrast agents have further been segmented into gadolinium-based, iron-based and manganese-based. C.T. contrast agents have further been segmented into iodine-based, barium-based, gold nanoparticles and gastrografin-based.
Application
- Monitoring Drug treatment response
- Bio distribution Studies
- Cancer cell Detection
- Biomarkers
- Longitudinal Studies
- Epigenetics
On the basis of application, the small animal (in-vivo) imaging market is segmented into monitoring drug treatment response, bio distribution studies, cancer cell detection, biomarkers, longitudinal studies and epigenetics.
Small Animal (In-Vivo) Imaging Market Regional Analysis/Insights
The small animal (in-vivo) imaging market is analysed and market size insights and trends are provided by country, modality, reagents, and application as referenced above.
The countries covered in the small animal (in-vivo) imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the small animal (in-vivo) imaging market because of the innovative modality innovations resulting from technological advancements in this region.
Europe is expected to grow during the forecast period due to the presence of large number of diagnostic device manufacturers in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The small animal (in-vivo) imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for small animal (in-vivo) imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the small animal (in-vivo) imaging market. The data is available for historic period 2010-2020.
Competitive Landscape and Small Animal (In-Vivo) Imaging Market Share Analysis
The Small animal (in-vivo) imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to small animal (in-vivo) imaging market.
Some of the major players operating in the small animal (in-vivo) imaging market are:
- Bruker (U.S.)
- General Electric (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Hitachi Ltd. (Japan)
- Siemens Healthcare GmbH (Germany)
- FUJIFILM Corporation (Japan)
- Bruker (U.S.)
- PerkinElmer Inc (U.S.)
- Miltenyi Biotec (Germany)
- CMR Naviscan (U.S.)
- SCANCO Medical AG (Switzerland)
- Aspect Imaging Ltd (Israel)
- Mediso Ltd (V.A.)
- LI-COR, Inc (USA)
- Takara Bio Inc (Japan)
- MILabs B.V. (Netherlands)
- M.R. Solutions (U.K.)
- Trifoil Imaging (U.S.)
- New England Biolabs (U.S.)
- Biospace Lab (France)
- Guerbet (France)
- Agilent Technologies, Inc (U.S.)
- Thermo Fisher Scientific Inc (U.S.)
Research Methodology : Global Small Animal (In-Vivo) Imaging Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-small-animal-vivo-imaging-market
SKU-